Proxy advisers split over endorsing Bayer management at AGM


FRANKFURT (Reuters) – Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer (BAYGn.DE), according to recommendations submitted by proxy voting firms.

FILE PHOTO: The logo of Bayer AG is seen in a showroom of the German drugmaker where the annual results news conference takes place in Leverkusen, Germany February 27, 2020. REUTERS/Wolfgang Rattay/File Photo

Bayer is due to host its annual general meeting on April 28 but the company still faces potentially huge litigation risks stemming from its $63 billion purchase of Monsanto in 2018.

One leading

Read More